Biogen Inc. buy Morgan Stanley
Start price
11.10.23
/
50%
€252.00
Target price
11.10.24
€339.70
Performance (%)
-31.35%
End price
12.10.24
€173.00
Summary
This prediction ended on 12.10.24 with a price of €173.00. The BUY prediction by Morgan_Stanley for Biogen Inc. performed very badly with a performance of -31.35%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 1.101% | 1.101% | 43.065% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Morgan Stanley from $381.00 to $361.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten